We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+14.55%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$24.6M
Cap. Flow
-$44M
Cap. Flow %
-4.18%
Top 10 Hldgs %
44.97%
Holding
105
New
25
Increased
29
Reduced
11
Closed
33

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$33.2M
2
BDX icon
Becton Dickinson
BDX
+$17.7M
3
ELV icon
Elevance Health
ELV
+$15.9M
4
TMO icon
Thermo Fisher Scientific
TMO
+$14.3M
5
DGX icon
Quest Diagnostics
DGX
+$13.7M

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$28.2M
2
ABBV icon
AbbVie
ABBV
+$24.6M
3
CRL icon
Charles River Laboratories
CRL
+$17.6M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$16.4M
5
ISRG icon
Intuitive Surgical
ISRG
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 95.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALKS icon
76
Alkermes
ALKS
$8.28B
– –
-250,000
Closed -$6.77M
ALNY icon
77
Alnylam Pharmaceuticals
ALNY
$29.3B
– –
-50,000
Closed -$7.47M
APLS
78
DELISTED
Apellis Pharmaceuticals
APLS
– –
-150,000
Closed -$8.82M
AUTL
79
Autolus Therapeutics
AUTL
$633M
– –
-500,000
Closed -$3.19M
AVTR icon
80
Avantor
AVTR
$9.29B
– –
-500,000
Closed -$12.8M
AXSM icon
81
Axsome Therapeutics
AXSM
$11.2B
– –
-30,000
Closed -$2.39M
COO icon
82
Cooper Companies
COO
$15B
– –
-110,000
Closed -$11.2M
COR icon
83
Cencora
COR
$63.1B
– –
-50,000
Closed -$12.1M
CRL icon
84
Charles River Laboratories
CRL
$13.4B
– –
-65,000
Closed -$17.6M
DXCM icon
85
DexCom
DXCM
$33.6B
– –
-100,000
Closed -$13.9M
EVH icon
86
Evolent Health
EVH
$456M
– –
-250,000
Closed -$8.2M
EXAS
87
CALL
DELISTED
Exact Sciences
EXAS
– –
-150,000
Closed -$10.4M
FDMT icon
88
4D Molecular Therapeutics
FDMT
$595M
– –
-250,000
Closed -$7.96M
GH icon
89
Guardant Health
GH
$22.2B
– –
-150,000
Closed -$3.09M
INSM icon
90
CALL
Insmed
INSM
$29B
– –
-500,000
Closed -$13.6M
INSP icon
91
Inspire Medical Systems
INSP
$1.73B
– –
-33,000
Closed -$7.09M
LH icon
92
Labcorp
LH
$26.1B
– –
-20,000
Closed -$4.37M
MGNX icon
93
MacroGenics
MGNX
$252M
– –
-500,000
Closed -$7.36M
MLTX icon
94
CALL
MoonLake Immunotherapeutics
MLTX
$1.39B
– –
-200,000
Closed -$10M
NTRA icon
95
Natera
NTRA
$45.7B
– –
-50,000
Closed -$4.57M
PEN icon
96
Penumbra
PEN
$12.9B
– –
-70,000
Closed -$15.6M
REGN icon
97
Regeneron Pharmaceuticals
REGN
$83.1B
– –
-17,000
Closed -$16.4M
RVTY icon
98
Revvity
RVTY
$13B
– –
-50,000
Closed -$5.25M
SAGE
99
DELISTED
Sage Therapeutics
SAGE
– –
-200,000
Closed -$3.75M
TNDM icon
100
Tandem Diabetes Care
TNDM
$1.65B
– –
-225,000
Closed -$7.97M
1 2 3
4
5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Integral Health Asset Management held 105 positions worth $1.05B, down 2.3% from $1.08B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Integral Health Asset Management withdrew a net $44M in Q2 2024, closing 33 positions and reducing 11 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $28.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 95% a quarter earlier.

Against the trend, Integral Health Asset Management opened a new position in Becton Dickinson worth $17.5M.

  • Integral Health Asset Management's largest Q2 2024 buy was Becton Dickinson: 75,000 shares worth $17.5M.
  • Integral Health Asset Management added most to Cytokinetics in Q2 2024, an estimated $33.2M increase.
  • Integral Health Asset Management's biggest Q2 2024 reduction was Intuitive Surgical, cutting an estimated $15.9M.
  • Integral Health Asset Management fully exited Walgreens Boots Alliance in Q2 2024, selling an estimated $28.2M.
  • Integral Health Asset Management's ten largest holdings make up 45% of its $1.05B portfolio in Q2 2024.
  • Integral Health Asset Management opened 25 new positions and closed 33 in Q2 2024.
  • Integral Health Asset Management's portfolio value fell 2.3% quarter-over-quarter to $1.05B.

Based on Integral Health Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.